ALK and non-small cell lung carcinoma: The purpose of this study was to identify CT imaging biomarkers using radiomic features extracted from pretreatment thoracic CT images for predicting BM in patients with ALK-rearranged NSCLC, focused on BM within 1 year after initial detection of the primary tumor.